BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Ye ZW, Yuan S, Poon KM, Wen L, Yang D, Sun Z, Li C, Hu M, Shuai H, Zhou J, Zhang MY, Zheng BJ, Chu H, Yuen KY. Antibody-Dependent Cell-Mediated Cytotoxicity Epitopes on the Hemagglutinin Head Region of Pandemic H1N1 Influenza Virus Play Detrimental Roles in H1N1-Infected Mice. Front Immunol 2017;8:317. [PMID: 28377769 DOI: 10.3389/fimmu.2017.00317] [Cited by in Crossref: 17] [Cited by in F6Publishing: 18] [Article Influence: 3.4] [Reference Citation Analysis]
Number Citing Articles
1 Gao R, Sheng Z, Sreenivasan CC, Wang D, Li F. Influenza A Virus Antibodies with Antibody-Dependent Cellular Cytotoxicity Function. Viruses 2020;12:E276. [PMID: 32121563 DOI: 10.3390/v12030276] [Cited by in Crossref: 8] [Cited by in F6Publishing: 8] [Article Influence: 4.0] [Reference Citation Analysis]
2 Von Holle TA, Moody MA. Influenza and Antibody-Dependent Cellular Cytotoxicity. Front Immunol 2019;10:1457. [PMID: 31316510 DOI: 10.3389/fimmu.2019.01457] [Cited by in Crossref: 20] [Cited by in F6Publishing: 22] [Article Influence: 6.7] [Reference Citation Analysis]
3 Yu F, Song H, Wu Y, Chang SY, Wang L, Li W, Hong B, Xia S, Wang C, Khurana S, Feng Y, Wang Y, Sun Z, He B, Hou D, Manischewitz J, King LR, Song Y, Min JY, Golding H, Ji X, Lu L, Jiang S, Dimitrov DS, Ying T. A Potent Germline-like Human Monoclonal Antibody Targets a pH-Sensitive Epitope on H7N9 Influenza Hemagglutinin. Cell Host Microbe 2017;22:471-483.e5. [PMID: 28966056 DOI: 10.1016/j.chom.2017.08.011] [Cited by in Crossref: 33] [Cited by in F6Publishing: 28] [Article Influence: 6.6] [Reference Citation Analysis]
4 Kang S, Kim Y, Shin Y, Song JJ, Jon S. Antigen-Presenting, Self-Assembled Protein Nanobarrels as an Adjuvant-Free Vaccine Platform against Influenza Virus. ACS Nano 2021;15:10722-32. [PMID: 34114799 DOI: 10.1021/acsnano.1c04078] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 3.0] [Reference Citation Analysis]
5 Khurana S. Development and Regulation of Novel Influenza Virus Vaccines: A United States Young Scientist Perspective. Vaccines (Basel) 2018;6:E24. [PMID: 29702547 DOI: 10.3390/vaccines6020024] [Cited by in Crossref: 8] [Cited by in F6Publishing: 9] [Article Influence: 2.0] [Reference Citation Analysis]
6 Lee WS, Wheatley AK, Kent SJ, DeKosky BJ. Antibody-dependent enhancement and SARS-CoV-2 vaccines and therapies. Nat Microbiol 2020;5:1185-91. [PMID: 32908214 DOI: 10.1038/s41564-020-00789-5] [Cited by in Crossref: 211] [Cited by in F6Publishing: 182] [Article Influence: 105.5] [Reference Citation Analysis]
7 Jegaskanda S. The Potential Role of Fc-Receptor Functions in the Development of a Universal Influenza Vaccine. Vaccines (Basel) 2018;6:E27. [PMID: 29772781 DOI: 10.3390/vaccines6020027] [Cited by in Crossref: 12] [Cited by in F6Publishing: 15] [Article Influence: 3.0] [Reference Citation Analysis]
8 van Erp EA, Luytjes W, Ferwerda G, van Kasteren PB. Fc-Mediated Antibody Effector Functions During Respiratory Syncytial Virus Infection and Disease. Front Immunol 2019;10:548. [PMID: 30967872 DOI: 10.3389/fimmu.2019.00548] [Cited by in Crossref: 68] [Cited by in F6Publishing: 65] [Article Influence: 22.7] [Reference Citation Analysis]
9 Zhu P, Yi X, Zhang L, Liu Y, Wang S, Gu J, Zhu X, Yu X. Identification of H7N9 hemagglutinin novel protein epitopes that elicit strong antibody-dependent, cell-mediated cytotoxic activities with protection from influenza infection in mouse model. Cell Immunol 2021;359:104255. [PMID: 33316647 DOI: 10.1016/j.cellimm.2020.104255] [Reference Citation Analysis]
10 Vanderven HA, Kent SJ. The protective potential of Fc-mediated antibody functions against influenza virus and other viral pathogens. Immunol Cell Biol 2020;98:253-63. [PMID: 31914207 DOI: 10.1111/imcb.12312] [Cited by in Crossref: 14] [Cited by in F6Publishing: 16] [Article Influence: 7.0] [Reference Citation Analysis]
11 Lam JH, Baumgarth N. The Multifaceted B Cell Response to Influenza Virus. J Immunol 2019;202:351-9. [PMID: 30617116 DOI: 10.4049/jimmunol.1801208] [Cited by in Crossref: 45] [Cited by in F6Publishing: 40] [Article Influence: 15.0] [Reference Citation Analysis]
12 Winarski KL, Tang J, Klenow L, Lee J, Coyle EM, Manischewitz J, Turner HL, Takeda K, Ward AB, Golding H, Khurana S. Antibody-dependent enhancement of influenza disease promoted by increase in hemagglutinin stem flexibility and virus fusion kinetics. Proc Natl Acad Sci U S A 2019;116:15194-9. [PMID: 31296560 DOI: 10.1073/pnas.1821317116] [Cited by in Crossref: 34] [Cited by in F6Publishing: 33] [Article Influence: 11.3] [Reference Citation Analysis]
13 Tan CS, Ghofrani J, Geiger E, Koralnik IJ, Jost S. Brief Report: Decreased JC Virus-Specific Antibody-Dependent Cellular Cytotoxicity in HIV-Seropositive PML Survivors. J Acquir Immune Defic Syndr 2019;82:220-4. [PMID: 31513076 DOI: 10.1097/QAI.0000000000002105] [Reference Citation Analysis]
14 Pascual-Iglesias A, Canton J, Ortega-Prieto AM, Jimenez-Guardeño JM, Regla-Nava JA. An Overview of Vaccines against SARS-CoV-2 in the COVID-19 Pandemic Era. Pathogens 2021;10:1030. [PMID: 34451494 DOI: 10.3390/pathogens10081030] [Cited by in Crossref: 2] [Article Influence: 2.0] [Reference Citation Analysis]
15 Kim YS, Aigerim A, Park U, Kim Y, Park H, Rhee JY, Choi JP, Park WB, Park SW, Kim Y, Lim DG, Choi JY, Jeon YK, Yang JS, Lee JY, Shin HS, Cho NH. Sustained Responses of Neutralizing Antibodies Against Middle East Respiratory Syndrome Coronavirus (MERS-CoV) in Recovered Patients and Their Therapeutic Applicability. Clin Infect Dis 2021;73:e550-8. [PMID: 32898238 DOI: 10.1093/cid/ciaa1345] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 3.0] [Reference Citation Analysis]
16 van Erp EA, Lakerveld AJ, de Graaf E, Larsen MD, Schepp RM, Hipgrave Ederveen AL, Ahout IM, de Haan CA, Wuhrer M, Luytjes W, Ferwerda G, Vidarsson G, van Kasteren PB. Natural killer cell activation by respiratory syncytial virus-specific antibodies is decreased in infants with severe respiratory infections and correlates with Fc-glycosylation. Clin Transl Immunology 2020;9:e1112. [PMID: 32099650 DOI: 10.1002/cti2.1112] [Cited by in Crossref: 4] [Cited by in F6Publishing: 9] [Article Influence: 2.0] [Reference Citation Analysis]
17 Chen X, Anderson LJ, Rostad CA, Ding L, Lai L, Mulligan M, Rouphael N, Natrajan MS, McCracken C, Anderson EJ. Development and optimization of a Zika virus antibody-dependent cell-mediated cytotoxicity (ADCC) assay. J Immunol Methods 2021;488:112900. [PMID: 33075363 DOI: 10.1016/j.jim.2020.112900] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
18 Kavian N, Hachim A, Poon LLM, Valkenburg SA. Vaccination with ADCC activating HA peptide epitopes provides partial protection from influenza infection. Vaccine 2020;38:5885-90. [PMID: 32718818 DOI: 10.1016/j.vaccine.2020.07.008] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]